November 05, 2008
By: by The Business Review
Nanotechnology's positive impact on the health care field will be the focus of a national conference scheduled for Nov. 7 at the
College of Nanoscale Science and Engineering
University at Albany
The event, titled "Symposium on the Convergence of Bio/Nanotechnology and Medicine," will be held from 8:30 a.m. to 4:45 p.m. the
complex's NanoFab 300 South.
The event will be presented jointly by the nanocollege and Empire State Science and Technology. It will bring together accomplished scientists, engineers, physicians and entrepreneurs working at the interface of nanotechnology and medicine. They will present cutting-edge developments and innovations in the field, and discuss opportunities and commercialization of nanomedicine.
Speakers will represent a variety of cross-sector institutions that are critical to developing and commercializing nanomedicine: higher education, including UAlbany's NanoCollege,
Massachusetts Institute of Technology
Rensselaer Polytechnic Institute
; research, such as
Roswell Park Cancer Institute
Long Island Jewish Medical Center
; and private industry, including
ImClone Systems Inc.
Nanomed Devices Inc.
The symposium kicks off Nov. 6 with a trade show, poster session and short courses.
Topics include such subjects as the role of nanoscale in regenerative medicine, dendrimer nanocomposites, nanotechnology and antibody therapeutics, deciphering extracellular matrix-induced stem cell differentiation, nanobiomaterials as building blocks for nanoelectronics, and getting a start-up funded.
Registration and booth-rental information is available